亚辉龙被监管警示 此前一个季度实控人套现8445.7万元

Core Viewpoint - The Shanghai Stock Exchange issued a regulatory warning to Shenzhen Yahui Long Biotechnology Co., Ltd. for inaccurate and incomplete information disclosure regarding its strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd. [1][2] Group 1: Regulatory Actions - The Shanghai Stock Exchange's management department decided to issue a regulatory warning to Yahui Long and its former board secretary Wang Mingyang due to violations of the listing rules [3] - The company is required to submit a rectification report within one month, signed by all directors and senior management, addressing the identified compliance issues [3] Group 2: Company Announcements - Yahui Long announced a strategic cooperation framework agreement with Brain Machine Star Chain, focusing on product development, market promotion, and equity investment [1] - Following media attention, Yahui Long issued a supplementary announcement clarifying that Brain Machine Star Chain's current research products are based solely on non-invasive technology and that some products are still in early development stages [1][2] Group 3: Market Reaction - The announcement led to a 6.52% increase in Yahui Long's stock price, with trading volume rising by 299% compared to the previous trading day [2] Group 4: Shareholder Actions - The controlling shareholder and chairman, Hu Kunhui, reduced his stake by 17,112,804 shares, representing 3% of the total shares, with a total transaction value of approximately 84.46 million yuan [4][5] - Another executive, Xiao Yujin, also reduced his holdings by 619,269 shares, accounting for 0.1086% of the total shares, with a total transaction value of approximately 9.20 million yuan [4][5] Group 5: Company Background - Yahui Long was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on May 17, 2021, with an initial public offering price of 14.80 yuan per share [6] - The company raised a total of approximately 606.8 million yuan, with net proceeds of about 541.33 million yuan after deducting issuance costs [6]

Shenzhen YHLO Biotech -亚辉龙被监管警示 此前一个季度实控人套现8445.7万元 - Reportify